Decreased Endomyocardial RANKL Expression in Transplant Coronary Artery Disease
- 27 May 2006
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 81 (10), 1467-1470
- https://doi.org/10.1097/01.tp.0000209413.45179.f6
Abstract
Transplant-associated coronary artery disease (TxCAD) appears to be initiated by endothelial cell activation and inflammation involving inflammatory cytokines and chemokines. Osteoprotegerin (OPG) and receptor activator of nuclear Factor-κB ligand (RANKL) have been implicated in cardiovascular disease progression and we measured the expression of these mediators in serum and myocardial biopsies taken serially during the first year after heart transplantation (HTx), relating them to the development of TxCAD. Serum OPG as well as myocardial gene expression of RANK and OPG, but not RANKL, were highest early after HTx and declined progressively. Importantly, patients who develop TxCAD or experience episodes of acute rejection showed a lower myocardial RANKL expression throughout the first year after transplantation than patients without these complications. Our findings may suggest an unrecognized role RANKL in maintaining myocardial and/or endothelial integrity and suggest that RANKL should be further investigated as a parameter that may predict development of TxCAD.Keywords
This publication has 17 references indexed in Scilit:
- Dysregulated Osteoprotegerin/RANK Ligand/RANK Axis in Clinical and Experimental Heart FailureCirculation, 2005
- Prognostic value of osteoprotegerin in heart failure after acute myocardial infarctionJournal of the American College of Cardiology, 2004
- Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survivalTransplant International, 2004
- Myocardial gene expression of inflammatory cytokines after heart transplantation in relation to the development of transplant coronary artery diseaseThe American Journal of Cardiology, 2003
- The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysisAmerican Journal of Kidney Diseases, 2003
- Increased Osteoprotegerin Serum Levels in Men with Coronary Artery DiseaseJournal of Clinical Endocrinology & Metabolism, 2003
- Modulation of LIGHT-HVEM Costimulation Prolongs Cardiac Allograft SurvivalThe Journal of Experimental Medicine, 2002
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Immunologic basis of transplant-associated arteriosclerosis.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findingsJournal of the American College of Cardiology, 1988